Today, it is officially launched!

/>

< /g>

On June 19, under the "Cloud Witness" of the 7 academicians of the Chinese Academy of Engineering and the Chinese Academy of Sciences and 30 experts in the country, it was used as a "nuclear weapon" for the treatment of liver tumors. Name: Yigantai®) is officially listed across the country.

< /g>

Academician of the Chinese Academy of Engineering, Dong Jiahong, Dean of Tsinghua University of Tsinghua University, Tsinghua University, Fan Jia, academician of the Chinese Academy of Sciences, Dean of Zhongshan Hospital affiliated to Fudan University, Liu Yunyi, an academician of the Chinese Academy of Sciences, professor of surgery at the Chinese University of Medicine, Academician of the Chinese Academy of Sciences, China Academy of Sciences Wang Xuehao, director of the Chinese Academy of Engineering, Wang Xuehao, director of the China Academy of Engineering, director of the Institute of Liver Cancer, the First Affiliated Hospital of Nanjing Medical University, Yu Jinming, academician of the Chinese Academy of Engineering, Dean of Shandong Cancer Hospital, Academician of the Chinese Academy of Engineering, Hepatobilia Zheng Shusen, director of the pancreas, participated in the 钇 [90Y] micro -ball injection listing meeting at the branch venues. The medicine will fully enter major hospitals to conduct precise intervention surgery for patients with liver cancer.

In China, about 400,000 primary liver cancer diagnose patients each year. At present, primary liver cancer is the fourth common malignant tumor in my country and the cause of death of the second tumor. For different patients with liver cancer, the treatment of liver cancer needs to create individual decision -making methods, and then implement accurate blows. Unlike the traditional abdominal operation, 钇 90 resin microspheres are more like a precise -guided micro -nuclear bomb. In the early stage, accurate positioning, the 钇 90 resin micro -ball with reasonable radiation will be directly reached inside the tumor by intervention. The ray concentrated quickly kills tumor cells, and it does not affect the surrounding health tissue. Compared with the traditional treatment mode, the precision treatment technology of the 钇 [90Y] resin microsphere has certain advantages. It has reduced the tumor to provide opportunities for later transformation therapy.

Since it was listed overseas in 2002, Sir-SPHERES® 钇 [90Y] Micro-ball injection cumulative treatment of over 120,000 patients in the world has obtained extensive clinical recognition of its safety and effectiveness. Guidelines issued by the United States Comprehensive Cancer Network (NCCN) and the British National Health Care Professional Organization (NICE) and other institutions recommend the treatment of liver metastasis of colorectal cancer. In 2018, Yuanda Pharmaceutical introduced Sir-SPHERES® 钇 [90Y] microsphere injection.

In September 2021, Dong Jiahong's multidisciplinary medical team led by Dong Jiahong implemented the first concession-90 resin microsphere for liver cancer surgery in Hainan Province. Fully retreat. In March of this year, the patient underwent liver tumor resection at Chang Geng Hospital in Beijing and obtained the final cure of advanced liver cancer. On January 30 this year, the Micro ball injection solution was approved by the State Drug Administration for listing, providing "nuclear weapons" level innovative treatment methods for Chinese liver cancer patients. Since February, the three hospitals in Tianjin, Shaanxi, Jiangsu, Hangzhou, Hunan, Liaoning, and Haikou have successfully implemented a number of patients with accurate intervention surgery for many patients.

Dr. Tang Weikun, President of Yuanda Pharmaceutical, introduced that with the gradual entering the domestic three hospitals, 钇 [90Y] micro -ball injection will provide a new and effective treatment for patients with malignant tumors in my country, create potential surgical resection opportunities to make up for the knot The gap in local treatment of rectal cancer liver metastasis marks that the field of liver malignant tumors in China has ushered in a new international and precise interventional treatment plan.

In the nine major venues of the country, 500 experts and professors from multi -disciplinary disciplines conducted extensive and in -depth academic discussions on the modern management and treatment of micro -ball injections.

- END -